Education
About Us
Working with TipRanks
Follow Us
MedinCell SA (FR:MEDCL)
:MEDCL
Total Valuation
MedinCell SA has a market cap or net worth of €519.35M. The enterprise value is €445.28M.
Market Cap€519.35M
Enterprise Value€445.28M
Share Statistics
MedinCell SA has 33,083,675 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding33,083,675
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
MedinCell SA’s return on equity (ROE) is 0.61 and return on invested capital (ROIC) is -79.01%.
Return on Equity (ROE)0.61
Return on Assets (ROA)-0.68
Return on Invested Capital (ROIC)-79.01%
Return on Capital Employed (ROCE)-1.02
Revenue Per Employee91.18K
Profits Per Employee-191.13K
Employee Count131
Asset Turnover0.32
Inventory Turnover-146.58
Valuation Ratios
The current PE Ratio of MedinCell SA is ―. MedinCell SA’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value-6.79
Price to FCF0.00
Price to Operating Cash Flow22.09
PEG Ratio―
Income Statement
In the last 12 months, MedinCell SA had revenue of 11.95M and earned -25.04M in profits. Earnings per share was -0.88.
Revenue11.95M
Gross Profit9.16M
Operating Income-20.98M
Pretax Income-24.95M
Net Income-25.04M
EBITDA-20.05M
Earnings Per Share (EPS)-0.88
Cash Flow
In the last 12 months, operating cash flow was 21.40M and capital expenditures -367.00K, giving a free cash flow of 21.03M billion.
Operating Cash Flow21.40M
Free Cash Flow21.03M
Free Cash Flow per Share0.64
Dividends & Yields
MedinCell SA pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.48
52-Week Price Change1.29%
50-Day Moving Average16.33
200-Day Moving Average15.75
Relative Strength Index (RSI)41.24
Average Volume (3m)77.62K
Important Dates
MedinCell SA upcoming earnings date is Dec 9, 2025, During Market Hours (Confirmed).
Last Earnings DateJun 17, 2025
Next Earnings DateDec 9, 2025
Ex-Dividend Date―
Financial Position
MedinCell SA as a current ratio of 1.66, with Debt / Equity ratio of -128.07%
Current Ratio1.66
Quick Ratio1.66
Debt to Market Cap0.20
Net Debt to EBITDA-1.97
Interest Coverage Ratio-4.54
Taxes
In the past 12 months, MedinCell SA has paid 88.00K in taxes.
Income Tax88.00K
Effective Tax Rate>-0.01
Enterprise Valuation
MedinCell SA EV to EBITDA ratio is -15.79, with an EV/FCF ratio of -24.14.
EV to Sales26.50
EV to EBITDA-15.79
EV to Free Cash Flow-24.14
EV to Operating Cash Flow-26.56
Balance Sheet
MedinCell SA has €38.85M in cash and marketable securities with €69.19M in debt, giving a net cash position of €30.34M billion.
Cash & Marketable Securities€38.85M
Total Debt€69.19M
Net Cash€30.34M
Net Cash Per Share€0.92
Tangible Book Value Per Share-€1.52
Margins
Gross margin is 100.00%, with operating margin of -175.61%, and net profit margin of -209.61%.
Gross Margin100.00%
Operating Margin-175.61%
Pretax Margin-208.87%
Net Profit Margin-209.61%
EBITDA Margin-167.82%
EBIT Margin-170.22%
Analyst Forecast
The average price target for MedinCell SA is €23.80, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€23.80
Price Target Upside51.40% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast-1.66%
EPS Growth Forecast-6.31%